Table 1. Type I collagen post-translational hydroxylation.
Hyl/(Hyl+Lys) | 4-Hyp/(Hyp+Pro) | % α2(I) P707 3-Hyp | % α1(I) P986 3-Hyp | % Telo Hyl (NH2, COOH) | |
+/+ | |||||
fibroblast | 20.0±1.5 | 49.5±1.3 | <10 | 97 | ND |
skin | 12.9±1.2 | 40.2±2.2 | 6–10 | 80 | ND |
osteoblast | 46.4±1.8 | 50.9±1.5 | 24 | 97 | ND |
femur | ND | ND | 13–21 | 98 | 85, 85 |
humerus | 24.8±3.2 | 45.4±1.2 | ND | ND | ND |
+/− | |||||
fibroblast | 21.7±0.8 | 48.5±0.9 | <10 | >89 | ND |
skin | 12.8±0.3 | 39.8±0.8 | 6–11 | 80 | ND |
osteoblast | ND | ND | 24 | 97 | ND |
femur | ND | ND | 10–12 | 98 | ND |
humerus | 30.1±0.2 | 46.1±1.4 | ND | ND | ND |
−/− | |||||
fibroblast | 20.1±1.0 | 51.2±1.2 | <10 | 11 | ND |
skin | 2.5±1.9 | 41.9±1.4 | 1–2 | 2 | ND |
osteoblast | 43.7±0.8 | 52.7±1.5 | 13 | 5 | ND |
femur | ND | ND | 5–7 | 2 | 95, 83 |
humerus | 30.8±3.4 | 45.1±1.1 | ND | ND | ND |
ND, Not determined.